跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BFI Breazco Capsule - NPRA Drug Approval Details
Approvals
/
NPRA
/
BFI Breazco Capsule
Approved
STANDARD
BFI Breazco Capsule
BF INTERNATIONAL SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 28, 2025
Approval ID
e07ccaec5db3cc16
Company
BF INTERNATIONAL SDN. BHD.
Type
Standard
Approval Details
Approval Id
e07ccaec5db3cc16
Drug Approval Npra Name
BFI Breazco Capsule
Product Name
BFI Breazco Capsule
Registration Number
MAL21106134TC
Holder Company Name
BF INTERNATIONAL SDN. BHD.
Holder Address
NO. 9, JALAN ASTANA 1B, BANDAR BUKIT RAJA, 41050 KLANG, SELANGOR. 41050 KLANG MALAYSIA
Holder Phone
0126399398
Manufacturer Company Name
GANOFARM R&D SDN BHD
Manufacturer Address
NO. 52, JALAN BAWAL 1, TAMAN MUTIARA, TANJUNG SEPAT, 42800 KUALA LANGAT MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL21106134TC
Version
1751614523
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 28, 2025
Approval ID
e07ccaec5db3cc16
Type
Standard
Source
Official Source
Back to NPRA Approvals